Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-27

Clinical Trial Update: Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

View source ↗

Summary

The Alzheimer's disease in Down syndrome trial (NCT04149197) sponsored by LuMind IDSC Foundation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LuMind IDSC Foundation | Conditions: Alzheimer's Disease in Down Syndrome | Status: TERMINATED